Amoxycillin /Sulbactum Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1250mg & 250mg
Reference Brands: Unasyn (USA), Moxclav-SB (India)
Category:
Antibiotics
Veterinary Amoxicillin & Sulbactam injection is useful due to Synergistic action & effective against almost all bacteria, Faster & Irreversible ß – lactamase inhibition, Broad spectrum bactericidal & Modern antibiotic combination, inhibits bacterial Cell wall synthesis, Excellent Tissue penetration & Anaerobic activity very minimal Plasma Protein binding, Cost effective & Excellent combination, Excellent safety record
Amoxycillin /Sulbactum Tablet is available in Tablets
and strengths such as 1250mg & 250mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amoxycillin /Sulbactum Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amoxycillin /Sulbactum Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amoxicillin Trihydrate / Sulbactam tablets are a combination antibiotic formulation used for the treatment of a wide range of bacterial infections. This combination pairs amoxicillin, a broad-spectrum penicillin antibiotic, with sulbactam, a beta-lactamase inhibitor that helps overcome bacterial resistance. Amoxicillin works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria, while sulbactam protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant organisms.
This synergistic action enhances the overall effectiveness of the treatment, making it particularly useful in infections caused by beta-lactamase–producing bacteria. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. The combination is widely used in emerging markets due to its improved efficacy compared to amoxicillin alone. It is generally well tolerated and is typically administered orally in tablet form, often as part of a broader antimicrobial therapy plan under medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing